CN Patent

CN105960249B — 胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂

Assigned to Sanofi Aventis France · Expires 2021-03-16 · 5y expired

What this patent protects

本发明公开了胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂。具体地，本申请涉及包含(a)至少一种胰岛素类似物和/或衍生物；和(b)Zn(II)；和(c)山梨醇；和(d)任选的鱼精蛋白的药物制剂。

USPTO Abstract

本发明公开了胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂。具体地，本申请涉及包含(a)至少一种胰岛素类似物和/或衍生物；和(b)Zn(II)；和(c)山梨醇；和(d)任选的鱼精蛋白的药物制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN105960249B
Jurisdiction
CN
Classification
—
Expires
2021-03-16
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis France
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.